Skip to main content
An official website of the United States government
Email

Matt Ehrhardt

Dr. Matt Ehrhardt, with brown eyes and glasses, sits at a desk, pen in hand, wearing a dress shirt and tie and looking pensively into the distance.

As a physician–scientist, Dr. Matt Ehrhardt splits his time between caring for young people newly diagnosed with lymphomas and researching the development of survivorship care guidelines for doctors.

Credit: National Cancer Institute

  • Associate Member, St. Jude Children’s Research Hospital
  • Co-Chair, Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult (AYA) Cancers

Dr. Matt Ehrhardt is passionate about ensuring survivors of childhood and AYA cancers get the care they need as they enter adulthood and middle age. Data from the St. Jude Lifetime Cohort Study helped his team uncover factors—such as living in an under-resourced area and having a chronic disease—linked to early death in childhood cancer survivors.

Matt also develops and disseminates guidelines, informed by those factors, that can help doctors recommend follow-up care to survivors. “There’s a lot of potential where we could use an aggregate data source to help primary care providers take care of these patients,” he said, adding that linking doctors to electronic health records (EHR) could provide them with past treatment data that would guide care.  

CCDI is striving to make that EHR data easier to extract and share, potentially improving care and accelerating research for all children and AYAs with cancer. 

Sign up to get stories like this and CCDI updates in your inbox

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Matt Ehrhardt was originally published by the National Cancer Institute.”

Email